Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroblastoma.

Titilope A Ishola1, Dai H Chung

  • 1Sealy Center for Cancer Cell Biology, The University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA.

Surgical Oncology
|November 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma.

Anticancer research·2026
Same author

Tradition and Transformation: The Legacy of the Southern Surgical Association in Changing Times.

Journal of the American College of Surgeons·2026
Same author

Carcinoma sequence inferred from increasing age at choledochal cyst excision.

Surgery·2025
Same author

Perioperative Blood Transfusion and Infectious Complications Among Pediatric Patients with Cancer.

Children (Basel, Switzerland)·2025
Same author

Caught in the Crossfire: 10-Year Experience with Pediatric Firearm Injury at a Single Institution.

Journal of the American College of Surgeons·2025
Same author

The impact of margins and re-resection in pediatric synovial sarcoma.

Cancer medicine·2024
Same journal

Long-term quality of life after cytoreductive surgery and HIPEC: A survivorship analysis.

Surgical oncology·2026
Same journal

Comparative safety of postoperative HIPEC with recombinant mutant TNF-α versus paclitaxel for gastric cancer peritoneal metastasis: a randomized controlled trial.

Surgical oncology·2026
Same journal

Early postoperative hospital exposome stress, multisystem recovery trajectories, and long-term oncologic outcomes after curative colorectal cancer surgery.

Surgical oncology·2026
Same journal

Prognostic significance of age in adult primary intestinal diffuse large B-cell lymphoma: Insights from the SEER database.

Surgical oncology·2026
Same journal

Total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis of long-term outcomes.

Surgical oncology·2026
Same journal

Associations of latent profiles of resilience and fear of progression with discharge symptoms and postoperative frailty among patients undergoing lung resection: A longitudinal study.

Surgical oncology·2026
See all related articles

Neuroblastomas are challenging pediatric cancers. Research focuses on new targets like the MYCN oncogene and angiogenesis, alongside epigenetic regulation and retinoic acid therapy for better treatment strategies.

Area of Science:

  • Pediatric Oncology
  • Cancer Biology
  • Molecular Therapeutics

Background:

  • Neuroblastomas present significant clinical challenges despite multimodal therapy advancements.
  • Poor prognostic indicators, including the MYCN oncogene and angiogenesis, are key research areas.
  • Recent discoveries highlight the role of epigenetic regulation and retinoic acid in neuroblastoma pathogenesis.

Purpose of the Study:

  • To explore novel therapeutic targets for neuroblastoma.
  • To investigate the role of MYCN oncogene and angiogenesis in disease progression.
  • To understand the impact of epigenetic modifications and retinoic acid on neuroblastoma.

Main Methods:

  • Review of current research on neuroblastoma targets.
  • Analysis of studies on MYCN oncogene and angiogenesis.

Related Experiment Videos

  • Examination of findings related to epigenetic regulation and retinoic acid therapy.

    • Main Results:

    • MYCN oncogene amplification and angiogenesis are critical poor prognostic factors.
    • Epigenetic dysregulation influences neuroblastoma development.
    • Retinoic acid therapy shows potential in managing neuroblastoma.

    Conclusions:

    • Understanding neuroblastoma complexity is crucial for developing innovative treatments.
    • Targeting MYCN, angiogenesis, and epigenetic pathways offers therapeutic potential.
    • Combinational therapy strategies hold promise for improved patient outcomes.